| NCT ID | NCT02584478 |
| Title | Phase 1/2a Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Advenchen Laboratories, LLC |
| Indications |
cervical adenosquamous carcinoma cervical squamous cell carcinoma ovarian clear cell adenocarcinoma |
| Therapies | |
| Age Groups: | adult senior |